Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group. [electronic resource] by
- Nielsen, Dorte Lisbet
- Bjerre, Karsten D
- Jakobsen, Erik H
- Cold, Søren
- Stenbygaard, Lars
- Sørensen, Peter G
- Kamby, Claus
- Møller, Susanne
- Jørgensen, Charlotte L T
- Andersson, Michael
Producer: 20120203
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|